---
title: "AGS released its 2024 annual performance, with a net profit attributable to the parent company of 293 million yuan, a year-on-year increase of 35.06%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/236984345.md"
description: "AGS released its 2024 annual performance, with operating revenue of 637 million yuan, a year-on-year increase of 25.14%; net profit attributable to the parent company of 293 million yuan, a year-on-year increase of 35.06%; net profit excluding non-recurring gains and losses of 273 million yuan, a year-on-year increase of 28.62%; basic earnings per share of 3.64 yuan/share. The company plans to distribute a cash dividend of 13.8 yuan (including tax) for every 10 shares"
datetime: "2025-04-22T13:04:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/236984345.md)
  - [en](https://longbridge.com/en/news/236984345.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/236984345.md)
generator: "portal-rs"
---

# AGS released its 2024 annual performance, with a net profit attributable to the parent company of 293 million yuan, a year-on-year increase of 35.06%

According to the Zhitong Finance APP, AGS (688581.SH) released its annual report for 2024, with an operating income of 637 million yuan for the year, a year-on-year increase of 25.14%; net profit attributable to shareholders of the listed company was 293 million yuan, a year-on-year increase of 35.06%; net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 273 million yuan, a year-on-year increase of 28.62%; basic earnings per share were 3.64 yuan/share. It is proposed to distribute a cash dividend of 13.8 yuan (including tax) for every 10 shares

### Related Stocks

- [688581.CN](https://longbridge.com/en/quote/688581.CN.md)

## Related News & Research

- [Vector Science files US provisional patent for orthopedic tissue-regeneration peptide platform](https://longbridge.com/en/news/296483037.md)
- [LIVE MARKETS-Why the energy shock hasn't been so bad for Europe this time](https://longbridge.com/en/news/296100071.md)
- [Soccerment Group Launches Sics Atlas, the First AI-Native Football Platform for Match Analysis and Scouting](https://longbridge.com/en/news/296495845.md)
- [Curql invests in pet healthcare platform Wagmo](https://longbridge.com/en/news/296396050.md)
- [09:02 ETEvolved By Nature's Peptide Platform Used in FDA-Cleared Prescription Therapy for the Management of Atopic Dermatitis](https://longbridge.com/en/news/296496101.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**